Interventional management alternatives in Budd-Chiari syndrome. Series of cases and review of the literature

Authors

DOI:

https://doi.org/10.59093/27112330.75

Keywords:

Budd-Chiari syndrome, hepatobiliary diseases, transjugular intrahepatic portosystemic shunt, hepatic cirrhosis, venous thrombosis

Abstract

Hepatic venous outflow tract obstruction, also known as Budd-Chiari syndrome, is a rare condition that causes hepatic congestion, portal hypertension, hepatocyte necrosis and eventually acute or chronic liver failure. Currently, the management of this condition represents a challenge for the physician, who must be prepared to determine the best alternative among the different therapeutic options available. This article aims to illustrate the alternatives of interventional management of this disease, through a series of cases of patients treated in the Interventional Radiology service of a referral hospital in the city of Medellin, between 2011 and 2017.

Downloads

Download data is not yet available.

Author Biographies

Emilio Sanín-Pérez, Hospital Pablo Tobón Uribe

Médico, Especialista en Radiología Intervencionista, Hospital Pablo Tobón Uribe. Medellín, Colombia.

Juan David Vásquez-Montoya, Universidad CES

Médico, Residente de Radiología. Grupo de Investigación de Radiología, Universidad CES. Medellín, Colombia.

Sergio Álvarez-Vallejo, Hospital Pablo Tobón Uribe

Médico, Especialista en Radiología Intervencionista. Jefe, Departamento de Radiología, Hospital Pablo Tobón Uribe. Medellín, Colombia.

References

Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis 2008;28:259-269. https://doi.org/10.1055/s-0028-1085094.

Valla DC. Budd-Chiari syndrome/hepatic venous outflow tract obstruction. Hepatol Int 2018;12:168-180. https://doi.org/10.1007/s12072-017-9810-5.

Garcia-Pagàn JC, Buscarini E, Janssen HL, Leebeck FW, Plessier A, Rubbia-Brandt L, et al. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016;64:179-202. https://doi.org/10.1016/j.jhep.2015.07.040.

Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013;57:1962-1968. https://doi.org/10.1002/hep.26306.

Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 2002;22:15-26. https://doi.org/10.1055/s-2002-23203.

Sharma A, Keshava SN, Eapen A, Elias E, Eapen CE. An update on the management of Budd-Chiari syndrome. Dig Dis Sci 2021;66:1780-1790. https://doi.org/10.1007/s10620-020-06485-y.

Hitawala AA, Gupta V. Budd-Chiari Syndrome. StatPearls. Treasure Island (FL) ineligible companies.: StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.

Grus T, Lambert L, Grusová G, Banerjee R, Burgetová A. Budd-Chiari syndrome. Prague Med Rep 2017;118:69-80. https://doi.org/10.14712/23362936.2017.6.

Zhang F, Wang C, Li Y. The outcomes of interventional treatment for Budd-Chiari syndrome: systematic review and meta-analysis. Abdom Imaging 2015;40:601-608. https://doi.org/10.1007/s00261-014-0240-8.

Hernaez R, Hamilton JP. Unexplained ascites. Clin Liver Dis (Hoboken) 2016;7:53-56. https://doi.org/10.1002/cld.537.

Faraoun SA, Boudjella MA, Debzi N, Benidir N, Afredj N, Guerrache Y, et al. Budd-Chiari syndrome: an update on imaging features. Clin Imaging 2016;40:637-646. https://doi.org/10.1016/j.clinimag.2016.01.006.

Darwish-Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009;151:167-175. https://doi.org/10.7326/0003-4819-151-3-200908040-00004.

Kuka WP, Nduati PK, Mwirigi A, Opio CK. Budd-Chiari syndrome and extensive inferior vena cava thrombosis treated with sequential interventional radiology and transjugular intrahepatic portosystemic shunting: A case report from Kenya. SAGE Open Med Case Rep 2023;11:2050313x231161190. https://doi.org/10.1177/2050313x231161190.

Qi XS, Ren WR, Fan DM, Han GH. Selection of treatment modalities for Budd-Chiari Syndrome in China: a preliminary survey of published literature. World J Gastroenterol 2014;20:10628-10636. https://doi.org/10.3748/wjg.v20.i30.10628.

Valla D, Hadengue A, el Younsi M, Azar N, Zeitoun G, Boudet MJ, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology 1997;25:814-819. https://doi.org/10.1002/hep.510250405.

Han G, Qi X, Zhang W, He C, Yin Z, Wang J, et al. Percutaneous recanalization for Budd-Chiari syndrome: an 11-year retrospective study on patency and survival in 177 Chinese patients from a single center. Radiology 2013;266:657-667. https://doi.org/10.1148/radiol.12120856.

Mammen T, Keshava S, Eapen CE, Moses V, Babu NR, Kurien G, et al. Intrahepatic collateral recanalization in symptomatic Budd-Chiari syndrome: a single-center experience. J Vasc Interv Radiol 2010;21:1119-1124. https://doi.org/10.1016/j.jvir.2010.03.008.

Rautou PE, Moucari R, Escolano S, Cazals-Hatem D, Denié C, Chagneau-Derrode C, et al. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management. Am J Gastroenterol 2009;104:1140-1146. https://doi.org/10.1038/ajg.2009.63.

Mukhiya G, Jiao D, Han X, Zhou X, Pokhrel G. Survival and clinical success of endovascular intervention in patients with Budd-Chiari syndrome: A systematic review. J Clin Imaging Sci 2023;13:5. https://doi.org/10.25259/jcis_130_2022.

Li MK, Ma LQ. Attach importance to the individualized treatment of adult portal hypertension based on etiology and pathogenesis: A review. Medicine (Baltimore) 2023;102:e33527. https://doi.org/10.1097/md.0000000000033527.

Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O'Grady J, et al. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006;44:520-528. https://doi.org/10.1016/j.jhep.2005.12.002.

Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WC, et al. The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol 2001;35:338-343. https://doi.org/10.1016/s0168-8278(01)00131-3.

Attwell A, Ludkowski M, Nash R, Kugelmas M. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic porto-systemic shunt and liver transplantation. Aliment Pharmacol Ther 2004;20:867-873. https://doi.org/10.1111/j.1365-2036.2004.02190.x.

DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009;49:1729-1764. https://doi.org/10.1002/hep.22772.

Downloads

Published

2023-09-01

How to Cite

Sanín-Pérez, E., Vásquez-Montoya, J. D., & Álvarez-Vallejo, S. (2023). Interventional management alternatives in Budd-Chiari syndrome. Series of cases and review of the literature . Hepatología, 4(3), 218–231. https://doi.org/10.59093/27112330.75

Issue

Vol. 4 No. 3 (2023): September-October

Section

Case reports

License

Copyright (c) 2023 Hepatología

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo
Escanea para compartir
QR Code